Delivery Order SPE2DB22D1200-SPE2DB25FN2VY
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,149.73 fixed-price delivery order is for the supply of Lisdexamfetamine 30 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is not associated with a set-aside program and is not part of a larger contract vehicle. However, Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.51 firm-fixed-price delivery order is for the supply of 4566802887 LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,344.54 firm fixed-price delivery order is for the supply of Lisdexamfetamine 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LISDEXAMFETAMINE 40 MG CAPSULES 100S, a medication used for the treatment of certain medical conditions. The contract has a ceiling value of $3,923.70 and is a firm fixed-price delivery order with a completion date of July 8, 2025. The contract is not set aside for any...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 20 mg dextroamphetamine-amphetamine capsules, a medication used to treat conditions such as ADHD. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $2,339.35 and a period of performance through May 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LISDEXAMFETAMINE 30 MG CAPSULE 100S, a medication, with a ceiling value of $4,933.06. The contract is a Delivery Order and has a Firm Fixed Price pricing type. The contract does not have a set-aside designation, indicating open competition. This contract award is part of a larger...
- This federal contract award, valued at $15,076.16, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566963272 - LISDEXAMFETAMINE 40 MG CAPSULE 100S, a prescription medication, with a period of performance through January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $1,620.72 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LISDEXAMFETAMINE 50 MG CAPSULE 100S. The award has an ultimate completion date of May 30, 2025 and is not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,834.44 and an ultimate completion date of May 29, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp is the prime contractor for this award and has previously been awarded a...
- This is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,797.98 contract is for the supply of 30mg capsules of dextroamphetamine-amphetamine, a medication used to treat attention deficit hyperactivity disorder (ADHD). The award is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026....
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN2VYDelivery Order
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,403.20 firm fixed-price contract is for the delivery of LISDEXAMFETAMINE 40 MG CAPSULE 90S, a medication used to treat conditions such as attention-deficit/hyperactivity disorder (ADHD). The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical. This IDC serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract has a performance period extending through December 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/30/25 |